ABOS
Price
$2.97
Change
+$0.02 (+0.68%)
Updated
Nov 5, 10:43 AM (EDT)
6 days until earnings call
UCBJY
Price
$97.31
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
114 days until earnings call
Ad is loading...

ABOS vs UCBJY

Header iconABOS vs UCBJY Comparison
Open Charts ABOS vs UCBJYBanner chart's image
Acumen Pharmaceuticals
Price$2.97
Change+$0.02 (+0.68%)
Volume$5K
CapitalizationN/A
UCB S.A
Price$97.31
Change-$0.00 (-0.00%)
Volume$129.97K
CapitalizationN/A
View a ticker or compare two or three
ABOS vs UCBJY Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABOS vs. UCBJY commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and UCBJY is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ABOS: $2.95 vs. UCBJY: $97.31)
Brand notoriety: ABOS and UCBJY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 101% vs. UCBJY: 610%
Market capitalization -- ABOS: $177.24M vs. UCBJY: $37.22B
ABOS [@Biotechnology] is valued at $177.24M. UCBJY’s [@Biotechnology] market capitalization is $37.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileUCBJY’s FA Score has 3 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • UCBJY’s FA Score: 3 green, 2 red.
According to our system of comparison, UCBJY is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while UCBJY’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 4 bearish.
  • UCBJY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, UCBJY is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +2.08% price change this week, while UCBJY (@Biotechnology) price change was +1.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.74%. For the same industry, the average monthly price growth was +10.27%, and the average quarterly price growth was +7.68%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

UCBJY is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-1.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UCBJY($37.2B) has a higher market cap than ABOS($177M). UCBJY YTD gains are higher at: 125.618 vs. ABOS (-23.177). UCBJY has higher annual earnings (EBITDA): 1.12B vs. ABOS (-62.11M). UCBJY has more cash in the bank: 689M vs. ABOS (260M). ABOS has less debt than UCBJY: ABOS (28.2M) vs UCBJY (3.04B). UCBJY has higher revenues than ABOS: UCBJY (5.45B) vs ABOS (0).
ABOSUCBJYABOS / UCBJY
Capitalization177M37.2B0%
EBITDA-62.11M1.12B-6%
Gain YTD-23.177125.618-18%
P/E RatioN/A146.71-
Revenue05.45B-
Total Cash260M689M38%
Total Debt28.2M3.04B1%
FUNDAMENTALS RATINGS
UCBJY: Fundamental Ratings
UCBJY
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSUCBJY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
38%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
64%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 21 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
33%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWRAX11.140.07
+0.63%
Fidelity Advisor Global Real Estate A
FIKVX13.660.03
+0.22%
Fidelity Advisor Asset Manager 20% Z
GSCGX35.17N/A
N/A
Goldman Sachs Large Cap Core A
TAGDX14.35N/A
N/A
Transamerica Large Growth R6
CIAOX47.66-0.31
-0.65%
Capital Advisors Growth Investor

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ABCL. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+3.69%
ABCL - ABOS
52%
Loosely correlated
+5.49%
GBIO - ABOS
49%
Loosely correlated
-1.81%
MGTX - ABOS
48%
Loosely correlated
+2.75%
INZY - ABOS
47%
Loosely correlated
+1.38%
NTLA - ABOS
47%
Loosely correlated
+2.30%
More

UCBJY and

Correlation & Price change

A.I.dvisor tells us that UCBJY and GBIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
-0.74%
GBIO - UCBJY
28%
Poorly correlated
-1.81%
VANI - UCBJY
26%
Poorly correlated
-2.33%
ABOS - UCBJY
24%
Poorly correlated
+3.69%
TNYA - UCBJY
23%
Poorly correlated
+24.70%
ARWR - UCBJY
23%
Poorly correlated
+2.92%
More